Advances in technology and knowledge of diabetes management have offered new options for individuals with diabetes to optimize their glycemic control. Coupled with self-management education, intensive diabetes management, multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII), is associated with a reduced risk of diabetes microvascular and macrovascular complications (1,2).